AbbVie Inc. (ABBV) News

AbbVie Inc. (ABBV): $168.59

2.03 (+1.22%)

POWR Rating

Component Grades








Add ABBV to Watchlist
Sign Up

Filter ABBV News Items

ABBV News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

ABBV News Highlights

  • For ABBV, its 30 day story count is now at 25.
  • Over the past 16 days, the trend for ABBV's stories per day has been choppy and unclear. It has oscillated between 1 and 4.
  • APP, TOP and BMY are the most mentioned tickers in articles about ABBV.

Latest ABBV News From Around the Web

Below are the latest news stories about ABBVIE INC that investors may wish to consider to help them evaluate ABBV as an investment opportunity.

The 3 Hottest Dividend Stocks to Watch in 2024

You know what I hate about the typical article about hottest dividend stocks to watch?

Josh Enomoto on InvestorPlace | January 1, 2024

Top 15 Value Stocks to Buy for 2024

In this article, we discuss top 15 value stocks to buy for 2024 picked by Joel Greenblatt. To skip the details about Mr. Greenblatt’s life, portfolio performance, and investment strategy, go directly to Top 5 Value Stocks to Buy for 2024. Investing offers an exciting and effective way of growing wealth over time. Value investing is […]

Yahoo | December 28, 2023

AbbVie (ABBV) Laps the Stock Market: Here's Why

AbbVie (ABBV) closed at $154.88 in the latest trading session, marking a +0.17% move from the prior day.

Yahoo | December 27, 2023

AstraZeneca (AZN) Set to Acquire Gracell for $1.2 Billion

AstraZeneca (AZN) is set to acquire clinical-stage biopharmaceutical company, Gracell, for a total deal value of up to $1.2 billion.

Yahoo | December 27, 2023

A Tale of Two Pharmas: Can Obesity Firms Continue Their Outperformance in 2024?

In pharma, a company can take a larger slice of the healthcare pie than peers, but it is still constrained by the size of the pie.

Yahoo | December 27, 2023

Small Caps Are On A Tear Including Speculative Biotechs

So far 2023 is going well with our game plan -an end-of-year seasonal rally coupled with a run in speculative biotechs driven by innovation. | December 26, 2023

AbbVie (NYSE:ABBV) Is Paying Out A Larger Dividend Than Last Year

AbbVie Inc.'s ( NYSE:ABBV ) dividend will be increasing from last year's payment of the same period to $1.55 on 15th of...

Yahoo | December 26, 2023

Karuna (KRTX) Up 48% on $14B Buyout Offer From Bristol Myers

Bristol Myers (BMY) is set to acquire Karuna (KRTX) for $330 per share. This transaction is expected to close in the first half of 2024.

Yahoo | December 26, 2023

AbbVie's Recent ImmunoGen Acquisition Looks Brilliant: Here's Why

The acquisition fills an immediate need with some extras to boot.

Yahoo | December 26, 2023

29 Undervalued Dividend Aristocrats: December 2023

The S&P 500 Dividend Aristocrats Index contains 67 dividend growth stocks called the Dividend Aristocrats. | December 25, 2023

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!